Webinar for Good manufacturing practices guidelines for active pharmaceutical ingredients (GUI-0104)
Drug Establishment Licensing Bulletin 128, February 15, 2022
Health Canada posted the Good manufacturing practices guidelines for active pharmaceutical ingredients (GUI-0104) on February 10, 2022 (refer to DEL Bulletin 125).
The Health Product Compliance Directorate has pre-recorded a webinar to outline key changes to these guidelines. You will also find contact information should you have any questions.
We chose this format so you can view it on your own schedule and at your own pace.
GC Collab access
The webinar is available through GC Collab at the following link:
To access this and other webinars, you must register with GC Collab if you are not already registered. To register to GC Collab, please provide your e-mail address to del.questions-leppp@hc-sc.gc.ca and you will receive an invite.
Once your account is created, you can access the Health Products Inspections and Licensing group page and then the GUI-0104 webinar in the Files section.
If you have any questions, please email us at api.questions-ipa@hc-sc.gc.ca.
Page details
- Date modified: